Testing for Microsatellite Instability and Deficient DNA Mismatch Repair
Testing for Microsatellite Instability and Deficient DNA Mismatch Repair
Citing the recent landmark tumor-agnostic approval of pembrolizumab for patients with microsatellite instability-high (M... Read more
18 Dec 2018
•
15mins
Tumor Mutation Burden Testing
Tumor Mutation Burden Testing
Vamsi Velcheti, MD, and David Rimm, MD, PhD, discuss the recent clinical trials that studied tumor mutation burden (TMB)... Read more
18 Dec 2018
•
18mins
PD-L1 Expression Testing
PD-L1 Expression Testing
Vamsi Velcheti, MD, and David Rimm, MD, PhD, discuss the high number of recent programmed death-lingad 1 (PD-L1) inhibit... Read more
18 Dec 2018
•
12mins
The Evolving Role of Biomarkers in Oncology
The Evolving Role of Biomarkers in Oncology
Vamsi Velcheti, MD, and Hossein Borghaei, DO, MS, discuss challenges in using programmed death ligand 1 (PD-L1) and tumo... Read more
18 Dec 2018
•
20mins